Changes in hyporesponsiveness to acute amphetamine and age differences in tyrosine hydroxylase immunoreactivity in the brain over adolescence in male and female rats.
We investigated hyposensitivity after amphetamine in early (postnatal Day 30; P30) and late (P45) adolescent rats compared to adults (P70) in experiment 1. Locomotor activity was measured for 1 hr after the first (acute) and second (24 hr later) injection of amphetamine (0.5 or 1.5 mg/kg). P30 and P45 rats were transiently hypoactive compared to adults, as indicated by reduced locomotor activity after acute amphetamine and enhanced activity after the second injection in adolescents only. In experiment 2, ovariectomy did not alter locomotor activity during habituation at any age compared to intact rats, and, as for intact adolescents, ovariectomized adolescents continued to be less active after amphetamine than adults, suggesting gonadal immaturity alone cannot account for age differences in experiment 1. However, ovariectomy attenuated the increase in activity after the second treatment. In experiment 3 involving untreated rats, tyrosine hydroxylase immunoreactivity was reduced in P30, P40, and P50 compared to P90 rats in the nucleus accumbens core and the medial prefrontal cortex. Thus, adolescents may have an increased threshold of behavioral activation that can be overcome with either a higher dose or with repeated amphetamine treatment, and may be related to changes in the dopamine system over development.
Mathews
Iva Z
IZ
Department of Psychology and Neuroscience Program, Brock University, St. Catharines, Ontario, Canada L2S 3A1.
Waters
Patti
P
McCormick
Cheryl M
CM
D000367:Age Factors; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000276:immunology; D002421:Caudate Nucleus / Q000187:drug effects / Q000201:enzymology / Q000276:immunology; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D042341:Gonadal Hormones / Q000378:metabolism; D006185:Habituation, Psychophysiologic; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D009714:Nucleus Accumbens / Q000187:drug effects / Q000201:enzymology / Q000276:immunology; D010052:Ovariectomy; D017397:Prefrontal Cortex / Q000187:drug effects / Q000201:enzymology / Q000276:immunology; D051381:Rats; D020318:Rats, Long-Evans; D014446:Tyrosine 3-Monooxygenase / Q000276:immunology* / Q000378:metabolism*
D000697:Central Nervous System Stimulants; D042341:Gonadal Hormones; D000661:Amphetamine; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine